Tyrosine kinase inhibitors for the treatment of acute myeloid leukemia: delineation of anti-leukemic mechanisms of action.

Tyrosine kinase inhibitors for the treatment of acute myeloid leukemia: delineation of anti-leukemic mechanisms of action.

Item
http://www.wikidata.org/entity/Q39526394
MEK/ERK dependent activation of STAT1 mediates dasatinib-induced differentiation of acute myeloid leukemia.A phase II study of the EGFR inhibitor gefitinib in patients with acute myeloid leukemiaInteraction between Her2 and Beclin-1 proteins underlies a new mechanism of reciprocal regulation.EGFR inhibitors exacerbate differentiation and cell cycle arrest induced by retinoic acid and vitamin D3 in acute myeloid leukemia cellsNew agents for acute myeloid leukemia: is it time for targeted therapies?FLT3 inhibition: a moving and evolving target in acute myeloid leukaemia.Azacytidine and erlotinib exert synergistic effects against acute myeloid leukemia.Erlotinib synergizes with the poly(ADP-ribose) glycohydrolase inhibitor ethacridine in acute myeloid leukemia cells.Identification of potential tissue-specific cancer biomarkers and development of cancer versus normal genomic classifiers.Effects of lapatinib on cell proliferation and apoptosis in NB4 cells.Azacitidine and Sorafenib Therapy in a Pediatric Patient With Refractory Acute Myeloid Leukemia With Monosomy 7 and Somatic PTPN11 Mutation.An eco-friendly direct spectrofluorimetric method for the determination of irreversible tyrosine kinase inhibitors, neratinib and pelitinib: application to stability studies.
P2860

Tyrosine kinase inhibitors for the treatment of acute myeloid leukemia: delineation of anti-leukemic mechanisms of action.

Item
http://www.wikidata.org/entity/Q39526394
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Tyrosine kinase inhibitors for ...... leukemic mechanisms of action.
@en
Tyrosine kinase inhibitors for ...... leukemic mechanisms of action.
@nl
type
label
Tyrosine kinase inhibitors for ...... leukemic mechanisms of action.
@en
Tyrosine kinase inhibitors for ...... leukemic mechanisms of action.
@nl
prefLabel
Tyrosine kinase inhibitors for ...... leukemic mechanisms of action.
@en
Tyrosine kinase inhibitors for ...... leukemic mechanisms of action.
@nl
P1433
P1476
P2093
P304
P31
P356
P407
P433
P478
P50
P577
P698
P921
P356
P1433
P1476
Tyrosine kinase inhibitors for ...... leukemic mechanisms of action.
@en
P2093
P304
P31
P356
P407
P433
P478
P50
P577
P698
P921